AP2001002164A0 - Use of phosphonoformic acid derivatives for treating infections. - Google Patents

Use of phosphonoformic acid derivatives for treating infections.

Info

Publication number
AP2001002164A0
AP2001002164A0 APAP/P/2001/002164A AP2001002164A AP2001002164A0 AP 2001002164 A0 AP2001002164 A0 AP 2001002164A0 AP 2001002164 A AP2001002164 A AP 2001002164A AP 2001002164 A0 AP2001002164 A0 AP 2001002164A0
Authority
AP
ARIPO
Prior art keywords
acid derivatives
treating infections
phosphonoformic acid
processes
compound
Prior art date
Application number
APAP/P/2001/002164A
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of AP2001002164A0 publication Critical patent/AP2001002164A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to the use of a compound of formula (i)for the prophylaxis and therapy of infectious processes in humans and animals, which processes are induced by bacteria, fungi or parasites. The inventive compound is also used as fungicidal, bactericidal or herbicidal agent in plans.
APAP/P/2001/002164A 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections. AP2001002164A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854310A DE19854310A1 (en) 1998-11-25 1998-11-25 Use of phosphonoformic acid derivatives for the therapeutic and prophylactic treatment of infections
PCT/EP1999/008964 WO2000030653A2 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections

Publications (1)

Publication Number Publication Date
AP2001002164A0 true AP2001002164A0 (en) 2001-06-30

Family

ID=7888924

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002164A AP2001002164A0 (en) 1998-11-25 1999-11-20 Use of phosphonoformic acid derivatives for treating infections.

Country Status (16)

Country Link
EP (1) EP1133302A2 (en)
JP (1) JP2002530343A (en)
CN (1) CN1328464A (en)
AP (1) AP2001002164A0 (en)
AU (1) AU1859100A (en)
BR (1) BR9915605A (en)
CA (1) CA2352511A1 (en)
CZ (1) CZ20011819A3 (en)
DE (1) DE19854310A1 (en)
EA (1) EA200100585A1 (en)
IL (1) IL142775A0 (en)
NO (1) NO20012540L (en)
OA (1) OA11718A (en)
PL (1) PL348354A1 (en)
TR (1) TR200101431T2 (en)
WO (1) WO2000030653A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315411T3 (en) * 2001-07-20 2009-04-01 Bioagency Ag ORGANOFOSPHORATED COMPOUNDS FOR THE ACTIVATION OF T GAMMA / DELTA CELLS.
CA2518763A1 (en) * 2003-03-14 2004-09-23 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US20050171063A1 (en) * 2003-10-20 2005-08-04 Pawan Malhotra Use of phosphono derivatives as anti-malarials
CN104940211B (en) * 2015-06-08 2018-06-19 广州万粤知识产权运营有限公司 Application of the betulic acid in antimycotic biofilm drug is prepared

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012604A1 (en) * 1993-11-05 1995-05-11 Aktiebolaget Astra Novel amino acid derivatives
SE9604582D0 (en) * 1996-12-13 1996-12-13 Astra Ab Novel compounds
RU2116790C1 (en) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Antiinfectious agent "repharm" for external using
DE19859668A1 (en) * 1998-06-24 1999-12-30 Hassan Jomaa Treating or preventing viral, bacterial, fungal or parasitic infections using bis-phosphonic acid compounds, also having herbicidal activity

Also Published As

Publication number Publication date
EA200100585A1 (en) 2002-04-25
CZ20011819A3 (en) 2001-12-12
EP1133302A2 (en) 2001-09-19
NO20012540L (en) 2001-07-24
CN1328464A (en) 2001-12-26
PL348354A1 (en) 2002-05-20
OA11718A (en) 2005-01-26
DE19854310A1 (en) 2000-06-29
NO20012540D0 (en) 2001-05-23
WO2000030653A3 (en) 2000-11-16
AU1859100A (en) 2000-06-13
TR200101431T2 (en) 2001-10-22
JP2002530343A (en) 2002-09-17
BR9915605A (en) 2001-08-14
IL142775A0 (en) 2002-03-10
WO2000030653A2 (en) 2000-06-02
CA2352511A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
BR0317564A (en) Compounds, compositions and methods for treating bacterial or fungal diseases
HK1007310A1 (en) Biguanide derivatives manufacturing method thereof and disinfectants containing the derivatives
ES2188795T3 (en) BENZOXACINE ANTIMICROBIAL AGENTS.
ATE142423T1 (en) AQUEOUS DISPERSIONS OF SULFONYL UREA DERIVATIVES
BR9407711A (en) Process cyclopeptide compound for the preparation of a cyclopeptide and parasiticide compound
NO331012B1 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
YU2201A (en) Phosphorous organic compounds and their use
AP2001002165A0 (en) Use of phosphonoformic acid derivatives for treating infections
WO2000044359A3 (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
MXPA04004557A (en) Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide derivative.
TR200101841T2 (en) The use of bisphosphonates to prevent infections and treat infections
AP2001002106A0 (en) Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide.
AP2001002164A0 (en) Use of phosphonoformic acid derivatives for treating infections.
WO2000044358A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
DK1349457T3 (en) Liquid antimicrobial agents